$17.37
-0.05[-0.29%]
Last update: 4:00PM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
$17.37
0[0.00%]
| Open17.560 | Close17.370 |
| Vol / Avg.394.829K / 473.461K | Mkt Cap1.219B |
| Day Range17.150 - 17.590 | 52 Wk Range10.290 - 20.650 |
Kiniksa Pharmaceuticals Stock (NASDAQ:KNSA), Key Statistics
Kiniksa Pharmaceuticals Stock (NASDAQ: KNSA) analysis, key statistics.
Valuation Measures
Enterprise Value
1B
Trailing P/E
5.29
Forward P/E
- -
PE Ratio (TTM)
5.29
PEG Ratio (TTM)
- -
Price / Sales (ttm)
4.44
Price / Book (mrq)
2.97
Price / EBITDA
30.84
Enterprise Value / EBITDA (TTM)
26.01
Earnings Yield
18.89%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
5.87
Tangible Book value per share
5.61
Total Liabilities (Quarterly)
72.7M
Total Assets
484.3M
Total Liabilities
72.7M
Profitability
Net income Growth
- -
Gross Margin
69.66%
Net Margin
20.95%
EBIT Margin
-4.41%
EBITDA Margin
-3.57%
Operating Margin
-4.41%
Kiniksa Pharmaceuticals Stock (NASDAQ:KNSA), Key Statistics
Kiniksa Pharmaceuticals Stock (NASDAQ: KNSA) analysis, key statistics.
Valuation Measures
Enterprise Value
1B
Trailing P/E
5.29
Forward P/E
- -
PE Ratio (TTM)
5.29
PEG Ratio (TTM)
- -
Price / Sales (ttm)
4.44
Price / Book (mrq)
2.97
Price / EBITDA
30.84
Enterprise Value / EBITDA (TTM)
26.01
Earnings Yield
18.89%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
5.87
Tangible Book value per share
5.61
Total Liabilities (Quarterly)
72.7M
Total Assets
484.3M
Total Liabilities
72.7M
Profitability
Net income Growth
- -
Gross Margin
69.66%
Net Margin
20.95%
EBIT Margin
-4.41%
EBITDA Margin
-3.57%
Operating Margin
-4.41%
Kiniksa Pharmaceuticals Stock (NASDAQ:KNSA), Key Statistics
Kiniksa Pharmaceuticals Stock (NASDAQ: KNSA) analysis, key statistics.
Valuation Measures
Enterprise Value
1B
Trailing P/E
5.29
Forward P/E
- -
PE Ratio (TTM)
5.29
PEG Ratio (TTM)
- -
Price / Sales (ttm)
4.44
Price / Book (mrq)
2.97
Price / EBITDA
30.84
Enterprise Value / EBITDA (TTM)
26.01
Earnings Yield
18.89%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
5.87
Tangible Book value per share
5.61
Total Liabilities (Quarterly)
72.7M
Total Assets
484.3M
Total Liabilities
72.7M
Profitability
Net income Growth
- -
Gross Margin
69.66%
Net Margin
20.95%
EBIT Margin
-4.41%
EBITDA Margin
-3.57%
Operating Margin
-4.41%
Kiniksa Pharmaceuticals Stock (NASDAQ:KNSA), Key Statistics
Kiniksa Pharmaceuticals Stock (NASDAQ: KNSA) analysis, key statistics.
Valuation Measures
Enterprise Value
1B
Trailing P/E
5.29
Forward P/E
- -
PE Ratio (TTM)
5.29
PEG Ratio (TTM)
- -
Price / Sales (ttm)
4.44
Price / Book (mrq)
2.97
Price / EBITDA
30.84
Enterprise Value / EBITDA (TTM)
26.01
Earnings Yield
18.89%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
5.87
Tangible Book value per share
5.61
Total Liabilities (Quarterly)
72.7M
Total Assets
484.3M
Total Liabilities
72.7M
Profitability
Net income Growth
- -
Gross Margin
69.66%
Net Margin
20.95%
EBIT Margin
-4.41%
EBITDA Margin
-3.57%
Operating Margin
-4.41%
Kiniksa Pharmaceuticals Stock (NASDAQ:KNSA), Key Statistics
Kiniksa Pharmaceuticals Stock (NASDAQ: KNSA) analysis, key statistics.
Valuation Measures
Enterprise Value
1B
Trailing P/E
5.29
Forward P/E
- -
PE Ratio (TTM)
5.29
PEG Ratio (TTM)
- -
Price / Sales (ttm)
4.44
Price / Book (mrq)
2.97
Price / EBITDA
30.84
Enterprise Value / EBITDA (TTM)
26.01
Earnings Yield
18.89%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
5.87
Tangible Book value per share
5.61
Total Liabilities (Quarterly)
72.7M
Total Assets
484.3M
Total Liabilities
72.7M
Profitability
Net income Growth
- -
Gross Margin
69.66%
Net Margin
20.95%
EBIT Margin
-4.41%
EBITDA Margin
-3.57%
Operating Margin
-4.41%
Kiniksa Pharmaceuticals Stock (NASDAQ:KNSA), Key Statistics
Kiniksa Pharmaceuticals Stock (NASDAQ: KNSA) analysis, key statistics.
Valuation Measures
Enterprise Value
1B
Trailing P/E
5.29
Forward P/E
- -
PE Ratio (TTM)
5.29
PEG Ratio (TTM)
- -
Price / Sales (ttm)
4.44
Price / Book (mrq)
2.97
Price / EBITDA
30.84
Enterprise Value / EBITDA (TTM)
26.01
Earnings Yield
18.89%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
5.87
Tangible Book value per share
5.61
Total Liabilities (Quarterly)
72.7M
Total Assets
484.3M
Total Liabilities
72.7M
Profitability
Net income Growth
- -
Gross Margin
69.66%
Net Margin
20.95%
EBIT Margin
-4.41%
EBITDA Margin
-3.57%
Operating Margin
-4.41%
Kiniksa Pharmaceuticals Stock (NASDAQ:KNSA), Key Statistics
Kiniksa Pharmaceuticals Stock (NASDAQ: KNSA) analysis, key statistics.
Valuation Measures
Enterprise Value
1B
Trailing P/E
5.29
Forward P/E
- -
PE Ratio (TTM)
5.29
PEG Ratio (TTM)
- -
Price / Sales (ttm)
4.44
Price / Book (mrq)
2.97
Price / EBITDA
30.84
Enterprise Value / EBITDA (TTM)
26.01
Earnings Yield
18.89%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
5.87
Tangible Book value per share
5.61
Total Liabilities (Quarterly)
72.7M
Total Assets
484.3M
Total Liabilities
72.7M
Profitability
Net income Growth
- -
Gross Margin
69.66%
Net Margin
20.95%
EBIT Margin
-4.41%
EBITDA Margin
-3.57%
Operating Margin
-4.41%
Kiniksa Pharmaceuticals Stock (NASDAQ:KNSA), Key Statistics
Kiniksa Pharmaceuticals Stock (NASDAQ: KNSA) analysis, key statistics.
Valuation Measures
Enterprise Value
1B
Trailing P/E
5.29
Forward P/E
- -
PE Ratio (TTM)
5.29
PEG Ratio (TTM)
- -
Price / Sales (ttm)
4.44
Price / Book (mrq)
2.97
Price / EBITDA
30.84
Enterprise Value / EBITDA (TTM)
26.01
Earnings Yield
18.89%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
5.87
Tangible Book value per share
5.61
Total Liabilities (Quarterly)
72.7M
Total Assets
484.3M
Total Liabilities
72.7M
Profitability
Net income Growth
- -
Gross Margin
69.66%
Net Margin
20.95%
EBIT Margin
-4.41%
EBITDA Margin
-3.57%
Operating Margin
-4.41%
Kiniksa Pharmaceuticals Stock (NASDAQ:KNSA), Key Statistics
Kiniksa Pharmaceuticals Stock (NASDAQ: KNSA) analysis, key statistics.
Valuation Measures
Enterprise Value
1B
Trailing P/E
5.29
Forward P/E
- -
PE Ratio (TTM)
5.29
PEG Ratio (TTM)
- -
Price / Sales (ttm)
4.44
Price / Book (mrq)
2.97
Price / EBITDA
30.84
Enterprise Value / EBITDA (TTM)
26.01
Earnings Yield
18.89%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
5.87
Tangible Book value per share
5.61
Total Liabilities (Quarterly)
72.7M
Total Assets
484.3M
Total Liabilities
72.7M
Profitability
Net income Growth
- -
Gross Margin
69.66%
Net Margin
20.95%
EBIT Margin
-4.41%
EBITDA Margin
-3.57%
Operating Margin
-4.41%